Palatin Technologies
PTN
#10723
Rank
C$19.2 M
Marketcap
C$10.79
Share price
-1.41%
Change (1 day)
N/A
Change (1 year)

Palatin Technologies (PTN) - Total assets

Total assets on the balance sheet as of March 2026 : C$18.53 Million

According to Palatin Technologies's latest financial reports the company's total assets are C$18.53 Million. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Palatin Technologies - Total assets on balance sheet (from 2001 to 2026)

Total assets by year

Year Total assets Change
2025-06-30C$4.44 M-69.74%
2024-06-30C$14.68 M-38.14%
2023-06-30C$23.74 M-48.87%
2022-06-30C$46.43 M-44.32%
2021-06-30C$83.39 M-27.76%
2020-06-30C$0.11 B-15.79%
2019-06-30C$0.13 B167.23%
2018-06-30C$51.3 M-30.51%
2017-06-30C$73.82 M424.73%
2016-06-30C$14.06 M-61.74%
2015-06-30C$36.77 M174.41%
2014-06-30C$13.4 M-49.16%
2013-06-30C$26.36 M381.18%
2012-06-30C$5.47 M-73.15%
2011-06-30C$20.4 M55.59%
2010-06-30C$13.11 M-13.52%
2009-06-30C$15.16 M-22.15%
2008-06-30C$19.48 M-57.04%
2007-06-30C$45.34 M1.99%
2006-06-30C$44.46 M1.85%
2005-06-30C$43.65 M17.93%
2004-06-30C$37.01 M20.96%
2003-06-30C$30.6 M63.37%
2002-06-30C$18.73 M-13.19%
2001-06-30C$21.57 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Johnson & Johnson
JNJ
C$281.59 B 1,518,912.80%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
C$159.81 B 861,997.65%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
C$6.87 B 36,997.08%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
C$59.85 M 222.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
C$2.14 B 11,484.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
C$1.99 B 10,651.89%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
C$8.39 M-54.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
C$0.70 B 3,714.71%๐Ÿ‡บ๐Ÿ‡ธ USA